Table 1.
Number of patients (male / female) | 24 (0/24) |
---|---|
Average age (years) a | 61.8 ± 13.4 |
Salivary secretion (g/30 s.) a | 0.076 ± 0.092 |
Major complications (cases) | |
Osteoporosis | 10 |
Rheumatism | 7 |
Hypertension | 7 |
Refractory gastroesophageal reflux disease | 6 |
Keratitis | 6 |
Diabetic | 5 |
Hyperlipidemia | 5 |
Systemic scleroderma | 4 |
Insomnia | 4 |
Clinical laboratory tests | |
Anti-SS-A b antibody (cases) | |
> 5 U/mL | 17 |
< 5 U/mL | 7 |
IgG (cases) | |
< 800 mg/dL | 2 |
800–1700 mg/dL | 9 |
> 1700 mg/dL | 11 |
Serum creatinine (mg/dL) a | 0.75 ± 0.24 |
Blood urea nitrogen (mg/dL) a | 14.6 ± 4.6 |
Aspartate aminotransferase (U/L) a | 23 ± 11 |
Alanine aminotransferase (U/L) a | 17 ± 7 |
a: Where indicated, data are expressed as means ± SD
b: Anti-Sjögren’s syndrome-related antigen A